Medical Implant Market Thumbnail Image

2020

Medical Implant Market

Medical Implant Market Size, Share, Competitive Landscape and Trend Analysis Report by Product Type and Biomaterial Type : Global Opportunity Analysis and Industry Forecast, 2020-2027

LS : Medical Devices & Supplies

Select an option
Author's: Sayali Shinde| Apoorva Srivastava | Roshan Deshmukh
Publish Date:

Get Sample to Email

Medical Implant Market Statistics - 2027

The global medical implants market size accounted for $85,389 million in 2019, and is expected to reach $147,464 million by 2027, registering a CAGR of 7.2% from 2020 to 2027.Medical implant is an artificial device or tissue, which is used to replace damaged biological structures or enhance an existing biological structure. Medical implants are used in areas such as cardiovascular, orthopedic, neurological, and dental ailments. Some of the implants are made from skin, bone, or other body tissues, whereas some are made from metal, plastic, or ceramic materials. Medical implants can be permanent or temporary and can be removed when they are no longer required. Risks and complications associated with medical implantation are infection, surgical failure, and implant failure.

What is the Impact of COVID-19 Pandemic on the Medical Implant Market?

Most markets are witnessing decline in growth rate, owing to the outbreak of COVID-19, including the medical implants market. In addition, the American College of Surgeons (ACS) has recently developed guidelines for triage of vascular surgery patients, suggesting that non-emergency peripheral vascular procedures such as endovascular therapy for claudication should be postponed. Moreover, in regions severely affected by COVID-19, vascular procedures have been reduced to life or limb salvaging cases, owing to new government directives or hospital guidelines. All these factors are anticipated to impact the medical implants market in the future.

medical-implant-market-2020-2027-1606982291

 

Rise in aging population and increase in prevalence of chronic diseases are some of the major driving factors for the medical implants market. Aged people are more susceptible to chronic diseases such as cardiovascular diseases, orthopedic disorders, endovascular diseases, and dental disorders, thus being the major users of medical implants. For instance, with the increasing aging population, the demand for tooth loss is expected to grow. According to the American Academy Of Implant Dentistry (AAID), about 3 million people in the U.S. currently have dental implants, and this number is expected to grow by 500,000 annually.

The growth of the global medical implants market is further driven by technological advancements in medical implants. Moreover, hike in disposable income, availability of better medical facilities, surge in number of cases with damaged limbs or organs caused by different accidents are the factors that play pivotal role in accelerating the growth of the medical implants market.

Furthermore, increase in awareness about the different types of medical implants among healthcare professionals boosts the medical implant market growth. In addition, initiatives from medical health insurance companies to support the critical health issues is facilitating the growth of the market, globally. Moreover, rise in government support to provide medical insurance coverage to downtrodden people in the society for their better health is fueling the demand for medical implants. However, high cost of treatment associated with medical implant and stringent approval process hamper the growth of the market.

Medical Implant Market
By Product
Your browser does not support the canvas element.

Cardiovascular Implants segment holds a dominant position in 2019 and would continue to maintain the lead over the forecast period.

 

Medical Implant Market Segmentation

The global medical implants market is segmented into product type, biomaterial, and region. On the basis product type, the market is categorized into orthopedic implants, cardiovascular implants, spinal implant, neurostimulators, ophthalmic implants, dental implants, facial implants, and breast implants. By biomaterial type, it is fragmented into metallic biomaterials, ceramic biomaterials, polymers biomaterials, and natural biomaterials. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, the UK, France, Spain, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Segment review

On the basis of product type, the orthopedic implants segment is expected to hold a major medical implants market share in the global market, 2019, and is anticipated to continue this trend throughout the forecast period, owing to rise in prevalence of osteoporosis among aging population and increase in physical illness such as obesity. In addition, by biomaterial, the metallic biomaterial segment dominated the global medical implants market, due to increase in R&D investments, rise in applications of biomaterials, surge in demand for plastic surgery, and favorable reimbursements scenario.

Medical Implant Market
By Biomaterial
Your browser does not support the canvas element.

Polymers Biomaterials Segment is projected as one of the most lucrative segment.

 

Snapshot of Asia-Pacific medical implant market

Asia-Pacific expected to hold a significant share in the market and presents lucrative opportunities for key players operating in the medical implant market, owing to increase in population, increase in awareness among consumers about these devices, and availability of trained healthcare professionals. In addition, rise in healthcare expenditure and improvement in healthcare infrastructure are expected to propel the medical implants market growth in the region.

The report provides comprehensive analysis of the key players operating in the medical implant market such as Medtronic Plc., Johnson and Johnson, Boston Scientific Corporation, Biotronik, LivaNova PLC, Globus Medical, Inc., NuVasive, Inc., Integra LifeSciences Holding Corporation, Institut Straumann AG, and Conmed Corporation.

Medical Implant Market
By Region
2027
North America 
Europe
Asia-Pacific
LAMEA

Asia Pacific region would exhibit the highest CAGR of 8.8% during 2020-2027.

 

Key Benefits for Stakeholders

  • The study provides an in-depth analysis of the medical implants market along with current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2019 to 2027, which is expected to enable stakeholders to capitalize on prevailing market opportunities.
  • The medical implants market size and estimations are based on a comprehensive analysis of key developments in the industry.
  • The key market players and their strategies have been analyzed to understand the competitive outlook of the medical implants market.

Key Market Segments

By Product Type

  • Orthopedic Implants
    • Reconstructive Joint Replacements
      • Knee Replacement Implants
      • Hip Replacement Implants
      • Extremities
    • Orthobiologics
    • Trauma & Craniomaxillofacial
    •  
  • Cardiovascular Implants
    • Pacing Devices
      • Cardiac Resynchronization Therapy Devices (CRTs)
        • CRT-P (CRT with pacemaker function)
        • CRT-D (CRT with pacemaker and ICD function)
      • Implantable Cardioverter Defibrillators (ICDs)
        • Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
        • Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
      • Implantable Cardiac Pacemakers (ICPs)
  • Stents
    • Coronary Stents
      • Drug-eluting Stents (DES)
      • Bare-metal Coronary Stents
      • Bioabsorbable Stents
    • Peripheral Stents
    • Iliac
    • Femoral–Popliteal
    • Renal
    • Carotid
  • Stent-related Implants
    • Synthetic Grafts
    • Vena Cava Filters
  • Structural Cardiac Implants
    • Mechanical Heart Valves
    • Implantable Ventricular-assist Devices
      • LVAD
      • RVAD
      • BIVAD
  • Spinal Implants
    • Spinal Fusion Implants
    • Spinal Bone Stimulators
    • Vertebral Compression Fracture (VCF) Devices
    • Motion Preservation Devices/Non-fusion Devices
  • Neurostimulators
    • Deep Brain Stimulation (DBS)
    • Sacral Nerve Stimulation (SNS)
    • Vagus Nerve Stimulation (VNS)
    • Spinal Cord Stimulation (SCS)
    • Other neurostimulators
  • Opthalmic Implants
    • Intraocular Lens
    • Glaucoma Implants
  • Dental Implants
    • Plate Form Dental Implants
    • Root Form Dental Implants
  • Facial Implants
  • Breast implants

By Biomaterial Type

  • Metallic Biomaterials
  • Ceramic Biomaterials
  • Polymers Biomaterials
  • Natural Biomaterials

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
  • Rest of Asia-Pacific
    • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players

  • Medtronic Plc.
  • Johnson and Johnson
  • Boston Scientific Corporation
  • Biotronik
  • LivaNova PLC
  • Globus Medical, Inc
  • NuVasive, Inc.
  • Integra LifeSciences Holding Corporation
  • Institut Straumann AG
  • Conmed Corporation

Medical Implant Market Report Highlights

Aspects Details
icon_5
By PRODUCT
  • Orthopedic Implants
    • Reconstructive joint replacements
      • Knee Replacement Implants
      • Hip Replacement Implants
      • Extremities
    • Orthobiologics
    • Trauma & Craniomaxillofacial
  • Cardiovascular Implants
    • Pacing Devices
      • Cardiac Resynchronization Therapy Devices (CRTs)
        • CRT-P (CRT with pacemaker function)
        • CRT-D (CRT with pacemaker and ICD function)
      • Implantable Cardioverter Defibrillators (ICDs)
        • Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
        • Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
      • Implantable Cardiac Pacemakers (ICPs)
    • Stents
      • Coronary Stents
        • Drug-eluting Stents (DES)
        • Bare-metal Coronary Stents
        • Bioabsorbable Stents
      • Peripheral Stents
      • Iliac
      • Femoral–Popliteal
      • Renal
      • Carotid
      • Stent-related Implants,
        • Synthetic grafts
        • Vena cava filters
      • Structural cardiac implants
        • Mechanical heart valves
        • Implantable ventricular-assist devices
  • Spinal Implant
    • Spinal fusion implants
    • Spinal bone stimulators
    • Vertebral Compression Fracture (VCF) Devices
    • Motion preservation devices/non-fusion devices
  • Neurostimulators
    • Deep Brain Stimulation (DBS)
    • Sacral Nerve Stimulation (SNS)
    • Vagus Nerve Stimulation (VNS)
    • Spinal Cord Stimulation (SCS)
    • Other neurostimulators
  • Ophthalmic Implants
    • Intraocular Lens
    • Glaucoma Implants
  • Dental Implants
    • Plate form dental implants
    • Root form dental implants
  • Facial Implants
  • Breast Implants
icon_6
By Biomaterial Type
  • Metallic Biomaterials
  • Ceramic biomaterials
  • Polymers biomaterials
  • Natural biomaterials
icon_7
Key Market Players

NUVASIVE, INC., JOHNSON & JOHNSON, Medtronic Plc., GLOBUS MEDICAL, INC., LivaNova PLC, Integra LifeSciences Holdings Corporation, CONMED Corporation, Institut Straumann AG, Boston Scientific Corporation, Biotronik, Inc.

Analyst Review

The medical implant market has piqued the interest of healthcare providers due to several benefits offered by these devices to monitor and treat clinical disorders. Furthermore, the adoption of medical implants such as cardiac, orthopedic, dental, and breast implants is anticipated to witness significant increase with rise in prevalence of chronic diseases and rapidly aging population. Furthermore, remarkable technological advancements have been witnessed in medical implants to provide advanced treatment options for the management of diseases. 

As the market is saturated with steady growth rate in developed nations, Asia-Pacific and LAMEA are expected to offer high growth opportunities to the key players.

The growth of the global market is further driven by surge in incidence of chronic diseases, rise in acceptance of medical implants, and improvement of healthcare infrastructure in emerging nations. However, high cost of treatment associated with medical implants, reimbursement issues, and stringent regulatory policies for the approval of these implants are expected to restrain the market growth. Currently, orthopedic implants is the largest segment of medical implant market. Increase in obesity and rise in incidence of osteoporosis-related fracture among all age groups are likely maintain the need for orthopedic interventions. In addition, emerging markets are gaining more importance for majority of medical implant manufacturers and distributors. A rapid growth was observed in the shipments of these devices to provide improved healthcare services in emerging nations, and this is expected to offset the challenging conditions in mature markets such as North America and Europe. North America is expected to dominate the global medical implant market during the forecast period, followed by Europe.

Author Name(s) : Sayali Shinde| Apoorva Srivastava | Roshan Deshmukh
Frequently Asked Questions?

The total market value of Medical Implant Market is $1,47,463.5 million in 2019.

The forcast period for Medical Implant Market is 2020 to 2027

The market value of Medical Implant Market in 2020 is $90,674.2 million.

The base year is 2019 in Medical Implant Market

Top companies such as,Medtronic plc, Johnson and Johnson, Boston Scientific Corporation, Biotronik, LivaNova PLC, Globus Medical, Inc., NuVasive, Inc., Integra LifeSciences Holding Corporation, Institut Straumann AG and Conmed Corporation held a high market position in 2019. These key players held a high market postion owing to the strong geographical foothold in all region

orthopedic implants segment is the most influencing segment owing to the stressful hyperactive lifestyle, unhealthy food habits, growing number of aging population and advancement in medical technologies.

The major factor that fuels the growth of the Medical Implant Market includes Increasing prevalence of chronic diseases and growing aging population are some of the major driving factors for the global medical implants market. Moreover, advancements in medical implants and rising awareness about artificial implants are also supporting the growth of the global medical implants market.

Medical implants are devices or tissues that are placed inside or on the surface of the body. Many implants are prosthetics, intended to replace missing body parts. Other implants deliver medication, monitor body functions, or provide support to organs and tissues

Medical implants are devices or tissues that are placed inside or on the surface of the body. Many implants are prosthetics, intended to replace missing body parts.

No, there is no value chain analysis provided in the Medical Implant Market report.

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020-2027